Header cover image

Hong Kong Pharmaceuticals & Biotech Top Growth Stocks

Results

6

0 new
According to our Simply Wall St analysis these are the best growth companies.. We look for companies with high forecasted growth and healthy balance sheets that can deliver sustained growth over the long term.

6 companies

Beijing Luzhu Biotechnology

Market Cap: HK$2.6b

A biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China.

2480

HK$13.10

7D

0%

1Y

-47.6%

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$1.9b

Engages in the development of drug engaged in the research, development and commercialization of pharmaceutical products.

2591

HK$4.08

7D

-38.3%

1Y

-92.3%

Cutia Therapeutics

Market Cap: HK$708.6m

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

2487

HK$1.95

7D

-12.6%

1Y

-79.6%

Ocumension Therapeutics

Market Cap: HK$4.3b

Engages in the research, discovery, development, and commercialization of ophthalmic therapies in China.

1477

HK$5.29

7D

-0.7%

1Y

-53.3%

CanSino Biologics

Market Cap: HK$14.2b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$29.48

7D

19.4%

1Y

-43.1%

InSilico Medicine Cayman TopCo

Market Cap: HK$23.3b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

3696

HK$40.62

7D

-8.8%

1Y

n/a